chlorpromazine has been researched along with debrisoquin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Benitez, J; Calandra, S; Campo, GM; Caputi, AP; Carrillo, JA; Spina, E | 1 |
| Tang, SW | 1 |
| Benitez, J; Buemi, AL; Caputi, AP; Cobaleda, J; Garcia, MA; Llerena, A; Piña, B; Spina, E | 1 |
| Bounameaux, Y | 1 |
| Cooper, JK; Hawes, EM; Korchinski, ED; Midha, KK; Muralidharan, G | 1 |
1 review(s) available for chlorpromazine and debrisoquin
| Article | Year |
|---|---|
Relevance of polymorphic drug oxidation in the use of neuroleptics in schizophrenia.
Topics: Amoxapine; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Asian People; Chlorpromazine; Debrisoquin; Humans; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Schizophrenia; White People | 1986 |
1 trial(s) available for chlorpromazine and debrisoquin
| Article | Year |
|---|---|
Quinidine inhibits the 7-hydroxylation of chlorpromazine in extensive metabolisers of debrisoquine.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Chromatography, High Pressure Liquid; Cross-Over Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Debrisoquin; Depression, Chemical; Enzyme Inhibitors; Humans; Hydroxylation; Male; Mixed Function Oxygenases; Oxidation-Reduction; Phenotype; Polymorphism, Genetic; Quinidine | 1996 |
6 other study(ies) available for chlorpromazine and debrisoquin
| Article | Year |
|---|---|
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Debrisoquine oxidation in an Italian population: a study in healthy subjects and in schizophrenic patients.
Topics: Adult; Chlorpromazine; Debrisoquin; Female; Humans; Italy; Male; Middle Aged; Oxidation-Reduction; Phenotype; Schizophrenia; White People | 1992 |
Debrisoquine oxidation in schizophrenic patients treated with neuroleptics.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Debrisoquin; Female; Humans; Hydroxylation; Isoquinolines; Male; Methotrimeprazine; Middle Aged; Oxidation-Reduction; Schizophrenia; Thioridazine | 1988 |
[Studies on the effect of various substances on platelet function with several methods].
Topics: Amphetamine; Anti-Anxiety Agents; Blood Platelets; Caffeine; Chlorpromazine; Debrisoquin; Dibenzazepines; Flurazepam; Guanethidine; Humans; Oxazoles; Papaverine; Phenytoin; Platelet Aggregation; Pyridines; Theophylline | 1973 |